DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/v3qsj8/u_s_markets_for) has announced the addition of the "U.S. Markets for Obesity Drugs & Devices" report to their offering.
The fact that the overweight, obese and morbidly obese population remains vastly undertreated (in the U.S. and worldwide) bodes very well for next-generation obesity drugs and devices, as it leaves significant room for companies to profit and grow revenues in the coming decade in a virtually untapped U.S. market, expected to be valued at more than $1.8 billion by the year 2020.
This dynamic, new report includes analyses of selected products, current/forecast markets, surgical procedure volumes, competitors, market share by supplier, and opportunities in the U.S. Obesity Drugs and Devices Market. Specifically, this report covers leading and emerging prescription-based weight loss (obesity) drugs, and minimally invasive medical devices, including: laparoscopic adjustable gastric banding (LAGB) systems, intragastric balloon systems, implantable gastric stimulation devices, and other emerging device-based technologies, including nonsurgical/incisionless, transorally inserted or next-generation minimally invasive weight loss device therapies.
In 2014, the total, combined U.S. market for new obesity drugs and (minimally invasive medical) devices for the treatment of obesity was estimated at approximately $374.7 million. Over the forecast period, the total market is expected to advance at a healthy, double-digit compound annual rate of 32.4%, from an estimated $455.4 million in 2015 to an estimated $1,852.1 million in the year 2020.
Key Topics Covered:
1. Obesity Drugs
1.1 Leading Obesity Drugs
1.2 Emerging Obesity Drugs
1.3 Market Analysis
2. Laparoscopic Adjustable Gastric Banding Systems
2.1 Leading LAGB Systems
2.2 Market Analysis
3. Intragastric Balloon Systems
3.1 Apollo Endosurgery
3.2 Hélioscopie
3.3 ReShape Medical
3.4 Spatz FGIA
3.5 Obalon Therapeutics
3.6 Market Analysis
4. Implantable Vagal Blocking Therapy
4.1 EnteroMedics
4.2 MetaCure
4.3 Market Analysis
5. Other Emerging Medical Device Technologies
5.1 Aspire Bariatrics
5.2 BAROnova
5.3 EndoSphere, Inc.
5.4 GI Dynamics
5.5 Onciomed
5.6 Scientific Intake
5.7 TransEnterix
5.9 USGI Medical
5.9 Others
For more information visit http://www.researchandmarkets.com/research/v3qsj8/u_s_markets_for
